BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29553339)

  • 1. Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.
    Bulens SN; Yi SH; Walters MS; Jacob JT; Bower C; Reno J; Wilson L; Vaeth E; Bamberg W; Janelle SJ; Lynfield R; Vagnone PS; Shaw K; Kainer M; Muleta D; Mounsey J; Dumyati G; Concannon C; Beldavs Z; Cassidy PM; Phipps EC; Kenslow N; Hancock EB; Kallen AJ
    Emerg Infect Dis; 2018 Apr; 24(4):727-734. PubMed ID: 29553339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
    Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
    JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.
    Latibeaudiere R; Rosa R; Laowansiri P; Arheart K; Namias N; Munoz-Price LS
    Clin Infect Dis; 2015 Feb; 60(3):415-22. PubMed ID: 25352586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between carbapenem use, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.
    Apisarnthanarak A; Jitpokasem S; Mundy LM
    Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1235-7. PubMed ID: 24113616
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia.
    Abdalhamid B; Hassan H; Itbaileh A; Shorman M
    New Microbiol; 2014 Jan; 37(1):65-73. PubMed ID: 24531172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
    Lu PL; Huang LY; Lian ST; Chang K; Lin CL; Hwang IJ; Chiang WG; Chen YH; Lin SF; Siu LK
    Int J Antimicrob Agents; 2008 May; 31(5):463-6. PubMed ID: 18359613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
    Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K
    J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India.
    Sinha N; Agarwal J; Srivastava S; Singh M
    Indian J Med Microbiol; 2013; 31(1):60-3. PubMed ID: 23508431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Vandepitte WP; Berge J; Andersson R
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S129-39. PubMed ID: 25509707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland.
    Ramette A; Kronenberg A;
    BMC Infect Dis; 2018 Apr; 18(1):159. PubMed ID: 29614963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States.
    Mera RM; Miller LA; Amrine-Madsen H; Sahm DF
    Microb Drug Resist; 2010 Sep; 16(3):209-15. PubMed ID: 20707714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of genotyping, antibiogram, and antimicrobial resistance genes between carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Chen CM; Ke SC; Li CR; Chang CC
    Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):339-46. PubMed ID: 25456639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation.
    Kempf M; Rolain JM; Azza S; Diene S; Joly-Guillou ML; Dubourg G; Colson P; Papazian L; Richet H; Fournier PE; Ribeiro A; Raoult D
    APMIS; 2013 Jan; 121(1):64-71. PubMed ID: 23030740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.
    Labarca JA; Salles MJ; Seas C; Guzmán-Blanco M
    Crit Rev Microbiol; 2016; 42(2):276-92. PubMed ID: 25159043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.